| 000 | 01705nam a22004098a 4500 | ||
|---|---|---|---|
| 005 | 20250918235744.0 | ||
| 006 | m|||||o||d|||||||| | ||
| 007 | cr|||||||||||| | ||
| 008 | 140812s2012||||enk s ||1 0|eng|d | ||
| 020 | _a9780511977640 (ebook) | ||
| 039 | 9 |
_a201408121015 _bnona _y08-12-2014 _znona |
|
| 040 |
_aUKM _erda |
||
| 090 | _aebook PHCTM | ||
| 245 | 0 | 0 |
_aEssential CNS Drug Development. / _cEdited by Amir Kalali, Sheldon Preskorn, Joseph Kwentus, Stephen M. Stahl. |
| 260 |
_aCambridge : _bCambridge University Press, _c2012. |
||
| 300 |
_a1 online resource (215 p.) : _bdigital, PDF file(s). |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 500 | _aTitle from publisher's bibliographic system (viewed on 08 Aug 2014). | ||
| 650 | 0 |
_aCentral Nervous System Agents _xpharmacology. |
|
| 650 | 0 |
_aClinical Trials as Topic _xmethods. |
|
| 650 | 0 |
_aDrug evaluation _xMethods. |
|
| 650 | 0 |
_aDrug Evaluation, Preclinical _xmethods. |
|
| 700 | 1 |
_aKalali, Amir. _eeditor of compilation. |
|
| 700 | 1 |
_aPreskorn, Sheldon. _eeditor of compilation. |
|
| 700 | 1 |
_aKwentus, Joseph. _eeditor of compilation. |
|
| 700 | 1 |
_aStahl, Stephen M. _eeditor of compilation. |
|
| 776 | 0 | 8 |
_iPrint version: _z9780521766067 |
| 856 | 4 | 0 | _uhttps://www-cambridge-org.eresourcesptsl.ukm.remotexs.co/core/books/essential-cns-drug-development/539C13C03B03A88B70684F4225DB5B80 |
| 856 | 4 | 0 |
_uhttp://dx.doi.org/10.1017/CBO9780511977640 _zAccess by subscription |
| 907 |
_a.b15963937 _b2023-06-29 _c2019-11-12 |
||
| 942 |
_n0 _kebook PHCTM |
||
| 914 | _avtls003566370 | ||
| 998 |
_ah _b2014-12-08 _cm _dz _feng _genk _y0 _z.b15963937 |
||
| 999 |
_c575766 _d575766 |
||